TipRanks Black Friday Sale
- Claim 60% off TipRanks Premium for the data-backed insights and research tools you need to invest with confidence.
- Subscribe to TipRanks' Smart Investor Picks and see our data in action through our high-performing model portfolio - now also 60% off
WuXi AppTec Co., Ltd. Class H ( (HK:2359) ) has provided an update.
WuXi AppTec Co., Ltd. has revised the terms of reference for its Remuneration and Appraisal Committee to enhance its corporate governance structure. The committee is tasked with evaluating the performance of directors and senior management, determining remuneration policies, and advising on share incentive plans, which are crucial for aligning management incentives with company goals and improving operational efficiency.
The most recent analyst rating on (HK:2359) stock is a Buy with a HK$133.00 price target. To see the full list of analyst forecasts on WuXi AppTec Co., Ltd. Class H stock, see the HK:2359 Stock Forecast page.
More about WuXi AppTec Co., Ltd. Class H
WuXi AppTec Co., Ltd. operates in the pharmaceutical and biotechnology industry, providing comprehensive laboratory and manufacturing services that support drug development and production. The company focuses on enabling global pharmaceutical, biotech, and medical device organizations to advance their research and bring new therapies to market.
Average Trading Volume: 9,084,704
Technical Sentiment Signal: Buy
Current Market Cap: HK$323.9B
For a thorough assessment of 2359 stock, go to TipRanks’ Stock Analysis page.